Pharmacovigilance – News and Features

News
Chicago Research Scientists Launch Precision Biomarker Resources
Four scientists from Children's Memorial Research Center in Chicago have launched the contract research organization based in Evanston, Illinois.

News
Insert Therapeutics, Receives FDA Approval for IT-101 Phase I Clinical Trial
Clinical Trials for Patented Nanotechnology-Based Therapeutic Set to Begin

News
BG Medicine to Conduct Joint Biomarker Discovery Study with Mitsubishi Pharma Corporation
BG Medicine has announced a collaborative preclinical research study into the biochemical origins of muscle toxicity and associated biomarkers with Mitsubishi Pharma Corp.

News
BGM Announces Collaborative Research Study with Mitsubishi Pharma
BG Medicine will apply their integrated systems approach to describe the molecular effects of selected lipid lowering agents on skeletal muscle.

News
eGene will be Granted Chinese Patent for DNA Analyzer Technology
Company has been granted a patent for "Optical detection in a multi-channel bio-separation system."

News
Compugen Leads Consortium to Model Cancer Related Kinase Pathway
The SIMAP consortium intends to develop a comprehensive simulation model of the pathway.

News
Genomics Revolution Creating Fundamental Changes in Drug Discovery
Genomics and proteomics sequencing creates new opportunities in the Asia pacific drug discovery market.

News
Iconix Extends Toxicogenomics Gene Expression Database to Affymetrix GeneChip® Platform
The extension of the DrugMatrix database will help researchers to make decisions earlier in the drug development process.

News
Shimadzu, Toppan and Third Wave Sign Agreement for Point-of-Care Instrument
The instrument is designed to analyzing a patient's DNA for specific gene sequences.

News
Ultrafast Genome Sequencer 20 System Finds its Application in Ever-Increasing Fields of Life Science Research
Roche Diagnostics have annouced that researchers have used the Genome Sequencer 20 technology to find the target and mechanism of action of a lead anti-TB agent.
Advertisement